QIAGEN NV (Austria) Today


EUR 45.44  1.51  3.44%   

Market Performance
1 of 100
Odds Of Distress
Over 52
QIAGEN NV is trading at 45.44 as of the 5th of July 2022. This is a 3.44 percent increase since the beginning of the trading day. The stock's open price was 43.93. QIAGEN NV has 52 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for QIAGEN NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 15th of July 2020 and ending today, the 5th of July 2022. Click here to learn more.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. QIAGEN NV operates under Diagnostics Research classification in Austria and is traded on Vienna Stock Exchange. The company has 227.34 M outstanding shares. More on QIAGEN NV
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

QIAGEN NV Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. QIAGEN NV's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding QIAGEN NV or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
QIAGEN NV has high likelihood to experience some financial distress in the next 2 years
About 74.0% of the company shares are owned by institutional investors
CEO, Managing DirectorPeer Schatz
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of QIAGEN NV's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
QIAGEN NV (QGEN) is traded on Vienna Stock Exchange in Austria and employs 6,000 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 9.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate QIAGEN NV's market, we take the total number of its shares issued and multiply it by QIAGEN NV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. QIAGEN NV operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 227.34 M outstanding shares. QIAGEN NV has accumulated about 1.23 B in cash with 717.78 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.41.
Check QIAGEN NV Probability Of Bankruptcy
QIAGEN NV secures a total of two hundred twenty-seven million three hundred fourty thousand outstanding shares. The majority of QIAGEN NV outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to secure positions in QIAGEN NV to benefit from reduced commissions. Thus, outside corporations are subject to a different set of regulations than regular investors in QIAGEN NV. Please pay attention to any change in the institutional holdings of QIAGEN NV as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check QIAGEN Ownership Details

QIAGEN Stock Price Odds Analysis

What are QIAGEN NV's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of QIAGEN NV jumping above the current price in 90 days from now is under 4%. The QIAGEN NV probability density function shows the probability of QIAGEN NV stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon QIAGEN NV has a beta of -0.1225 indicating as returns on benchmark increase, returns on holding QIAGEN NV are expected to decrease at a much lower rate. During the bear market, however, QIAGEN NV is likely to outperform the market. Additionally, the company has an alpha of 0.0747, implying that it can generate a 0.0747 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 45.44HorizonTargetOdds Above 45.44
96.43%90 days
Based on a normal probability distribution, the odds of QIAGEN NV to move above the current price in 90 days from now is under 4 (This QIAGEN NV probability density function shows the probability of QIAGEN Stock to fall within a particular range of prices over 90 days) .

QIAGEN NV Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. QIAGEN NV market risk premium is the additional return an investor will receive from holding QIAGEN NV long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in QIAGEN NV. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although QIAGEN NV's alpha and beta are two of the key measurements used to evaluate QIAGEN NV's performance over the market, the standard measures of volatility play an important role as well.

QIAGEN Stock Against Markets

Picking the right benchmark for QIAGEN NV stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in QIAGEN NV stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for QIAGEN NV is critical whether you are bullish or bearish towards QIAGEN NV at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in QIAGEN NV without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Efficient Frontier Now


Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Investing QIAGEN NV

You need to understand the risk of investing before taking a position in QIAGEN NV. The danger of trading QIAGEN NV is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of QIAGEN NV is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than QIAGEN NV. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile QIAGEN NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please see Your Equity Center. Note that the QIAGEN NV information on this page should be used as a complementary analysis to other QIAGEN NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Tools for QIAGEN Stock

When running QIAGEN NV price analysis, check to measure QIAGEN NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QIAGEN NV is operating at the current time. Most of QIAGEN NV's value examination focuses on studying past and present price action to predict the probability of QIAGEN NV's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move QIAGEN NV's price. Additionally, you may evaluate how the addition of QIAGEN NV to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios